Clinical Trial: Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Prostate Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Dose HRS-5041 in Healthy Caucasian Male Participants
Brief Summary:
This is a phase 1, open-label, randomized study.The objective of this study is to evaluate the PK, safety and tolerability of orally administered single-dose HRS-5041 in healthy Caucasian male participants.
Read more